Marina Biotech, Inc.

Published Date: 20/12/2011
Category: Therapies & Markets

Research Report Decription

Marina Biotech, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

• Detailed information on Marina Biotech, Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Marina Biotech, Inc. in the form of a SWOT analysis
• An in-depth view of the business model of Marina Biotech, Inc. including a breakdown and examination of key business segments
• Intelligence on Marina Biotech, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Marina Biotech, Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Key Questions Answered:

• Gain understanding of the Marina Biotech, Inc. and the factors that influence its strategies 

• Track strategic initiatives of the company and latest corporate news and actions 

• Assess Marina Biotech, Inc. as a prospective partners, vendor or supplier

• Support sales activities by understanding your customers' businesses better

• Stay up to date on Marina Biotech, Inc.’s business structure, strategy and prospects

Companies Mentioned:

Marina Biotech, Inc

Paper Highlights:

Marina Biotech (formerly MDRNA) is a biotechnology company focused on the development and commercialization of therapeutic products based on RNA interference (RNAi). The company has implemented a multi-faceted, multi-disciplinary and multi-technology approach to discovering novel and proprietary RNAi-based therapeutics. Marina Biotech is headquartered in Bothell, Washington and employed 46 people as of March 15, 2010. The company recorded revenues of $14.7 million during the financial year (FY) ended December 2009, as compared to the revenues of $2.6 million in FY2008. The operating loss of the company was $10.7 in FY2009, as compared to an operating loss of $58.9 million in FY2008. The net loss was $8.1 million in FY2009, as compared to a net loss of $59.2 million in FY2008.